CN1611248A - Chinese medicine composition for treating rheumatoid disease - Google Patents

Chinese medicine composition for treating rheumatoid disease Download PDF

Info

Publication number
CN1611248A
CN1611248A CN 200310105379 CN200310105379A CN1611248A CN 1611248 A CN1611248 A CN 1611248A CN 200310105379 CN200310105379 CN 200310105379 CN 200310105379 A CN200310105379 A CN 200310105379A CN 1611248 A CN1611248 A CN 1611248A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
weight portion
grams
weight portions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200310105379
Other languages
Chinese (zh)
Other versions
CN100459986C (en
Inventor
蒋艳群
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2003101053794A priority Critical patent/CN100459986C/en
Publication of CN1611248A publication Critical patent/CN1611248A/en
Application granted granted Critical
Publication of CN100459986C publication Critical patent/CN100459986C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Chinese medicine composition for radically curing rheumatoid disease. Said composition contains 35-45 weight portions of thunder god vine and 55-65 weight portions of lonicera stem and leaf, if the patient's condition is serious, in the composition 8.2-13.2 weight portions of moghania root, 30.7-45.7 weight portions of jiucengcao, 16.5-26.55 weight portions of mistletoe and 27.1-32 weight portions of cyathula root can be added. Said invented Chinese medicine composition can obtain notablet effect, and has not any toxic side effect.

Description

The rheumatoid Chinese medicine composition of a kind of treatment
Technical field:
The present invention relates to a kind of radical cure and treat rheumatoid Chinese medicine composition.
Technical background:
Rheumatoid disease many by wind, cold, damp etc. invade meridians, the numbness resistance is obstructed, introduce toadstool and cause.At present, China's Chinese and western medicine all has treatment to rheumatoid disease, but only control with medicine, medicine stops ailing recurrence, be difficult to radical cure, it is a kind of commonly encountered diseases, is again a kind of difficult disease, most of patients disables or lifelong pain, very big to people's livelihood harm, radical cure pertinacious disease rheumatoid is for the people remove difficulties and alleviate sufferings, have great social significance and social benefit, existing domestic traditional integrative therapy rheumatoid has adopted anti-inflammatory analgetics such as cortisone, Phenylbutazone, Radix Tripterygii Wilfordii tablet, Ying Taiqing, can not effect a radical cure, medical expenses are higher simultaneously, and the patient is difficult to bear its financial burden.
Summary of the invention:
The purpose of this invention is to provide a kind of radical cure and treat rheumatoid Chinese medicine composition.
It is a kind of that to effect a radical cure base stock and the weight proportion for the treatment of rheumatoid Chinese medicine composition as follows:
Radix Tripterygii Wilfordii 35-45 weight portion, Caulis Lonicerae 55-65 weight portion.
Heavy as the state of an illness, also can add Radix Flemingiae Philippinensis 8.2-13.2 weight portion, Herba Clinopodii Polycephali 30.7-45.7 weight portion, Herba Taxilli 16.5-26.55 weight portion, Radix Cyathulae medicine 27.1-32 weight portion.
Therapeutic Method of the present invention adopts traditional Chinese herbal medicine of China's uniqueness, has that medical expense is economized, its medicine and whole medical expense be traditional 25% less than it, and advantages such as drug resource is very abundant are arranged again.(1), obvious effective rate: pain disappears, and joint function recovery 82 examples account for 72.6%.(2), effective percentage: pain relief, function of joint improve 13 examples, account for 11.5%.(3), total effective rate: account for 84.1%.(4), contrast general integrative medicine therapy, effective percentage raising 35.4%.Medicine of the present invention is the therapy that adopts with pain analgesia and treating the poisonous disease with poisonous drugs simultaneously, does not promptly damage its health, can effect a radical cure rehabilitation again, no longer recurrence from now on, and the present invention was accumulated at clinical treatment 113 examples in 5 years, and its effect is remarkable, has no side effect.
The specific embodiment
1, get raw material by following weight: Radix Tripterygii Wilfordii 35-45 weight portion, Caulis Lonicerae 55-65 weight portion then adds three bowls in water to medicament mixed, decocts into one bowl, then oral, day clothes potion, twice on the one, one after each meal is taken about one month continuously, can effect a radical cure rheumatoid disease effectively.
2, if state of an illness weight person in the raw material of embodiment 1, also can add Radix Flemingiae Philippinensis 8.2-13.2 weight portion, Herba Clinopodii Polycephali 30.7-45.7 weight portion, Herba Taxilli 16.5-26.5 weight portion, Radix Cyathulae 27.1-32 weight portion, then medicament mixed is added three bowls in water, decoct into one bowl, then oral, day clothes potion, twice on the one, one after each meal is taken about one month continuously, can effect a radical cure rheumatoid disease effectively.
3, get raw material by following weight: Radix Tripterygii Wilfordii 10 grams, Caulis Lonicerae 15 grams for once decocting oral consumption, then add three bowls in water to medicament mixed, decoct into one bowl, then oral, day clothes potion, twice on the one, one after each meal is taken about one month continuously, can effect a radical cure rheumatoid disease effectively.
4, if state of an illness weight person in the raw material of embodiment 3, also can add Radix Flemingiae Philippinensis 3 grams, Herba Clinopodii Polycephali 9 grams, Herba Taxilli 6 grams, Radix Cyathulae 7 grams, then medicament mixed is added three bowls in water, decoct into one bowl, then oral, day clothes potion, twice on the one, one after each meal is taken about one month continuously, can effect a radical cure rheumatoid disease effectively.
In order to strengthen the effect of Drug therapy, period in a medicine, can tie electrotherapy hot compress patient's joint and acupuncture point, perhaps in conjunction with massaging, massaging and press patient's periosteum and acupuncture point with qigong tact skill makes and tightened by muscle or the joint of atrophy loosens levelling, make unimpeded by the acupuncture point meridian of rheumatoid toxin numbness resistance, metabolism recovers, get rid of toxin.Because of stimulating the central nervous system, promote the comprehensive function curative effect simultaneously with maneuver.

Claims (4)

1, a kind of radical cure is treated rheumatoid Chinese medicine composition and is made up of following materials of weight proportions: Radix Tripterygii Wilfordii 35-45 weight portion, Caulis Lonicerae 55-65 weight portion.
2, rheumatoid Chinese medicine composition is treated in a kind of radical cure according to claim 1, and raw material also can add the medicine of following weight proportion: Radix Flemingiae Philippinensis 8.2-13.2 weight portion, Herba Clinopodii Polycephali 30.7-45.7 weight portion, Herba Taxilli 16.5-26.55 weight portion, Radix Cyathulae 27.1-32 weight portion.
3, rheumatoid Chinese medicine composition is treated in a kind of radical cure according to claim 1, is made up of following materials of weight proportions: Radix Tripterygii Wilfordii 10 grams, Caulis Lonicerae 15 grams.
4, treat rheumatoid Chinese medicine composition according to claim 1 or claim 2 or the described a kind of radical cure of claim 3, raw material also can add the medicine of following weight proportion: Radix Flemingiae Philippinensis 3 grams, Herba Clinopodii Polycephali 9 grams, Herba Taxilli 6 grams, Radix Cyathulae 7 grams.
CNB2003101053794A 2003-10-30 2003-10-30 Chinese medicine composition for treating rheumatoid disease Expired - Fee Related CN100459986C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2003101053794A CN100459986C (en) 2003-10-30 2003-10-30 Chinese medicine composition for treating rheumatoid disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2003101053794A CN100459986C (en) 2003-10-30 2003-10-30 Chinese medicine composition for treating rheumatoid disease

Publications (2)

Publication Number Publication Date
CN1611248A true CN1611248A (en) 2005-05-04
CN100459986C CN100459986C (en) 2009-02-11

Family

ID=34757280

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2003101053794A Expired - Fee Related CN100459986C (en) 2003-10-30 2003-10-30 Chinese medicine composition for treating rheumatoid disease

Country Status (1)

Country Link
CN (1) CN100459986C (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1141119C (en) * 2001-02-02 2004-03-10 郑春雷 Capsule and its production process

Also Published As

Publication number Publication date
CN100459986C (en) 2009-02-11

Similar Documents

Publication Publication Date Title
CN100998656A (en) Medicated wine for tonifying bone and removing obstruction in channels
CN101164573A (en) Traditional Chinese medicine for treating cold stagnation infantile hernia
CN101152354A (en) Traditional Chinese medicine for treating acute dacryocystitis
CN105012585A (en) Traditional Chinese medicine for treating rhinitis
CN102475868A (en) Anti-rheumatism medicinal liquor
CN101940739A (en) Traditional Chinese medicine for treating gout
CN101757455A (en) Traditional Chinese medicine preparation for treating epilepsy
CN101721651B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN100411648C (en) Medicine for treating atrophic arthritis
CN105311420A (en) Traditional Chinese medicine composition for treating stroke and sequelae thereof
CN101181427B (en) Externally used medicament for curing scaly tetter
CN101152343A (en) Traditional Chinese medicine for treating chronic dacryocystitis
CN103550446B (en) Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition
CN100459986C (en) Chinese medicine composition for treating rheumatoid disease
CN102218105B (en) Medicinal liquor for treating psoriasis and method for producing same
CN101143199A (en) Traditional Chinese medicine for treating chronic bronchitis
CN101195006B (en) Exterior applying medicament for treating toothache due to pathogenic wind-fire
CN101129630B (en) Medicament for treating rheumatism, arthritis pauperum
CN102526544B (en) Oral powder Chinese medicine formula for treating lumbar disc herniation and osteoproliferation
CN101596297B (en) Tinea-curing pill
CN101134098A (en) Traditional Chinese medicine for treating biliary ascariasis
CN101322787B (en) Specific medicinal liquor for treating rheumatoild disease
CN101143183A (en) Traditional Chinese medicine for treating intractable headache
CN1203884C (en) Medication for treating rheumatism
CN1110604A (en) Medicinal liquor for treatment of arthritis and promoting collateral and channels

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090211

Termination date: 20151030

EXPY Termination of patent right or utility model